Oral shedding of herpesviruses and clinical outcomes in hematopoietic stem cell transplant patients

Imagem de Miniatura
Arquivos
art_MIRANDA-SILVA_Oral_shedding_of_herpesviruses_and_clinical_outcomes_in_2023.PDF (422.32 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
MIRANDA-SILVA, Wanessa
MOLLA, Vinicius Campos de
KNEBEL, Franciele Hinterholz
ARRAIS-RODRIGUES, Celso
CAMARGO, Anamaria Aranha
FREGNANI, Eduardo Rodrigues
Citação
ORAL DISEASES, v.29, n.2, p.815-826, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives To characterize the oral shedding of herpes viruses in patients who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT) and investigate its relationship with clinical outcomes. Materials and Methods Polymerase chain reaction and enzymatic digestion were performed to identify the oral shedding of the members of the Herpesviridae family in 31 patients. The samples were collected from the oral cavity at five timestamps. Results The presence of each herpesvirus in the oral cavity was observed in 3.2%, 12.9%, 19.3%, 32.2%, 54.8% and 93.5% patients for human herpesvirus (HHV)-6A, herpes simplex virus-1, HHV-6B, cytomegalovirus (CMV), Epstein-Barr virus (EBV) and HHV-7, respectively. Oral shedding of herpes virus was not uncommon after alloHSCT. There was a statistically significant association between the EBV and CMV oral shedding at C1 and the cumulative incidence of acute graft-versus-host disease (aGVHD). The results suggested that the presence of HSV-1 at C2 was related to a relapse. The HHV-7 oral shedding at C2 suggests a possible link between relapse, progression-free survival and overall survival of the patients. Conclusions Patients who developed aGVHD showed higher CMV and EBV shedding in the oral cavity at aplasia, suggesting modifications to the pattern of immune cell response and inflammatory microenvironment.
Palavras-chave
clinical outcomes, DNA virus infections, dysbiosis, hematopoietic stem cell transplantation, Herpesviridae
URI
https://observatorio.fm.usp.br/handle/OPI/53282
Referências
  1. Akahoshi Y, 2021, CLIN INFECT DIS, V73, pE620, DOI 10.1093/cid/ciaa1871
  2. de Oliveira PGAG, 2016, TRANSPLANTATION, V100, P1363, DOI 10.1097/TP.0000000000000986
  3. Aoki J, 2015, BIOL BLOOD MARROW TR, V21, P2017, DOI 10.1016/j.bbmt.2015.07.022
  4. Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004
  5. Bhutani D, 2015, BIOL BLOOD MARROW TR, V21, P159, DOI 10.1016/j.bbmt.2014.10.004
  6. Biganzoli P, 2010, J MED VIROL, V82, P1679, DOI 10.1002/jmv.21880
  7. Boutolleau D, 2003, J INFECT DIS, V187, P179, DOI 10.1086/367677
  8. Chemaly RF, 2020, CLIN INFECT DIS, V71, P2365, DOI 10.1093/cid/ciz1210
  9. Chevallier P, 2010, BONE MARROW TRANSPL, V45, P1204, DOI 10.1038/bmt.2009.326
  10. Clark DA, 2003, SEMIN HEMATOL, V40, P154, DOI 10.1016/S0037-1963(03)70007-9
  11. de Pagter PJA, 2013, BONE MARROW TRANSPL, V48, P1460, DOI 10.1038/bmt.2013.78
  12. Dockrell DH, 2001, REV MED VIROL, V11, P23, DOI 10.1002/rmv.299
  13. Doki N, 2013, TRANSPL INFECT DIS, V15, P314, DOI 10.1111/tid.12073
  14. Dulery R, 2012, BIOL BLOOD MARROW TR, V18, P1080, DOI 10.1016/j.bbmt.2011.12.579
  15. Gerdemann U, 2013, BLOOD, V121, P207, DOI 10.1182/blood-2012-05-430413
  16. Gimnez E, 2019, AM J TRANSPLANT, V19, P2479, DOI 10.1111/ajt.15515
  17. Girmenia C, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13666
  18. Griffiths PD, 2000, J ANTIMICROB CHEMOTH, V45, P29, DOI 10.1093/jac/45.suppl_4.29
  19. Han TT, 2021, TRANSPL INFECT DIS, V23, DOI 10.1111/tid.13544
  20. Harris AC, 2016, BIOL BLOOD MARROW TR, V22, P4, DOI 10.1016/j.bbmt.2015.09.001
  21. Hentrich M, 2005, BRIT J HAEMATOL, V128, P66, DOI 10.1111/j.1365-2141.2004.05254.x
  22. Hong J, 2020, KOREAN J INTERN MED, V35, P1188, DOI 10.3904/kjim.2018.469
  23. Inazawa N, 2015, J MED VIROL, V87, P1427, DOI 10.1002/jmv.24161
  24. Jagasia MH, 2015, BIOL BLOOD MARROW TR, V21, P389, DOI 10.1016/j.bbmt.2014.12.001
  25. Jaskula E, 2010, TRANSPL P, V42, P3273, DOI 10.1016/j.transproceed.2010.07.027
  26. Jeulin H, 2013, TRANSPLANTATION, V95, P1292, DOI 10.1097/TP.0b013e318289958b
  27. Johnson G, 2000, J CLIN MICROBIOL, V38, P3274, DOI 10.1128/JCM.38.9.3274-3279.2000
  28. Kanbayashi Y, 2017, ANN HEMATOL, V96, P311, DOI 10.1007/s00277-016-2883-8
  29. Kawamura K, 2013, TRANSPL INFECT DIS, V15, P457, DOI 10.1111/tid.12118
  30. Laberko A, 2017, BIOL BLOOD MARROW TR, V23, P483, DOI 10.1016/j.bbmt.2016.12.635
  31. Lee CJ, 2018, BIOL BLOOD MARROW TR, V24, P1783, DOI 10.1016/j.bbmt.2018.04.003
  32. Li Q, 2016, ONCOTARGET, V7, P30230, DOI 10.18632/oncotarget.8803
  33. Ljungman P, 2000, BRIT J HAEMATOL, V111, P774, DOI 10.1046/j.1365-2141.2000.02422.x
  34. Maeda Y, 1999, BRIT J HAEMATOL, V105, P295, DOI 10.1111/j.1365-2141.1999.01290.x
  35. Magalhaes IM, 2010, MEM I OSWALDO CRUZ, V105, P925, DOI 10.1590/S0074-02762010000700015
  36. Majhail NS, 2015, BIOL BLOOD MARROW TR, V21, P1863, DOI 10.1016/j.bbmt.2015.07.032
  37. Miranda-Silva W, 2020, CLIN ORAL INVEST, V24, P3597, DOI 10.1007/s00784-020-03234-3
  38. Morfin F, 2004, J CLIN VIROL, V30, P341, DOI 10.1016/j.jcv.2004.03.002
  39. Olson AL, 2014, BIOL BLOOD MARROW TR, V20, P787, DOI 10.1016/j.bbmt.2014.02.010
  40. Palmieri M, 2018, J ORAL MICROBIOL, V10, DOI 10.1080/20002297.2018.1476643
  41. Palmieri M, 2017, CLIN ORAL INVEST, V21, P2291, DOI 10.1007/s00784-016-2022-x
  42. Pawlowska AB, 2021, TRANSPL INFECT DIS, V23, DOI 10.1111/tid.13453
  43. Pereira CM, 2007, ORAL DIS, V13, P329, DOI 10.1111/j.1601-0825.2006.01294.x
  44. SARAL R, 1983, ANN INTERN MED, V99, P773, DOI 10.7326/0003-4819-99-6-773
  45. Styczynski J, 2016, J CLIN ONCOL, V34, P2212, DOI 10.1200/JCO.2015.64.2405
  46. Tang FF, 2017, J CLIN VIROL, V95, P20, DOI 10.1016/j.jcv.2017.07.018
  47. van der Beek MT, 2012, BONE MARROW TRANSPL, V47, P1222, DOI 10.1038/bmt.2012.2
  48. Wang LR, 2008, BONE MARROW TRANSPL, V42, P673, DOI 10.1038/bmt.2008.238
  49. Wang LR, 2006, BIOL BLOOD MARROW TR, V12, P1031, DOI 10.1016/j.bbmt.2006.06.001
  50. Ward KN, 2019, HAEMATOLOGICA, V104, P2155, DOI 10.3324/haematol.2019.223073
  51. Wu MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077805
  52. Xuan L, 2013, TRANSPLANTATION, V96, P560, DOI 10.1097/TP.0b013e31829d38af
  53. Yamamoto Y, 2014, J MED VIROL, V86, P505, DOI 10.1002/jmv.23782
  54. Yamane A, 2007, BIOL BLOOD MARROW TR, V13, P100, DOI 10.1016/j.bbmt.2006.09.003
  55. Yoshimoto G, 2018, BIOL BLOOD MARROW TR, V24, P2540, DOI 10.1016/j.bbmt.2018.07.017
  56. Zhou L, 2020, CLIN TRANSPLANT, V34, DOI 10.1111/ctr.13856

Coleções
Artigos e Materiais de Revistas Científicas - LIM/52
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - ODS/03